Autopsy report · NCT00149539

Abuse Potential of Buprenorphine/Naloxone

“Funding ended for the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months after it had already started.
• Ran for about 1 year 7 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

National Institute on Drug Abuse (NIDA)

Sponsor type

US National Institutes of Health

Conditions

Opioid-Related Disorders

Interventions

Buprenorphine/naloxone

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• Managing Chronic Tendon Pain by Metformin
  “The study funding has ended.” (93% match in meaning)
• Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction
  “funding for the study was terminated” (90% match in meaning)
• Changes in Bone Turnover With Increased Incretin Hormone Exposure
  “Study closed by sponsor. Funding ended.” (89% match in meaning)
• Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
  “The study terminated due to funding ending.” (89% match in meaning)
• Pharmacogenetic Testing for Medication Management.
  “Loss of funding for the continuation of the Study” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.